Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
EXUBERA®(insulin human [rDNA origin]) Inhalation PowderEXUBERA® Inhaler
Medication labelWhy this: Advisory · dailymed-prescription
EXUBERA is indicated for the treatment of adult patients with diabetes mellitus for the control of hyperglycemia. EXUBERA has an onset of action similar to rapid-acting insulin analogs and has a duration of glucose-lowering activity comparable to subcutaneously administered regular human insulin. In patients with type 1 diabetes, EXUBERA should be used in regimens that include a longer-acting insulin. In patients with type 2 diabetes, EXUBERA can be used as monotherapy or in combination with oral agents or longer-acting insulins.
- generic_name
- insulin human
- brand_name
- Exubera
- product_names
- insulin human, Exubera
- ndc
- 0069-0050, 0069-0050-85, 0069-0050-19, 0069-0050-53, 0069-0707, 0069-0707-37, 0069-0724, 0069-0724-37
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en